4/8/2024 | DD | Amyris reports $25.68 million net loss for January
|
3/15/2024 | DD | Amyris secures bankruptcy court approval of Lavvan settlement
|
3/12/2024 | DD | Amyris seeks bankruptcy court approval of Lavvan settlement
|
2/28/2024 | DD | Amyris reports $67.16 million net loss for December
|
2/7/2024 | DD | Amyris gets confirmation of amended Chapter 11 plan of reorganization
|
1/19/2024 | DD | Amyris’ Chapter 11 plan releases draw pushback from U.S. trustee
|
1/18/2024 | DD | Amyris cancels auction for its Lab-to-Market assets
|
1/8/2024 | DD | Amyris secures 90-day extension of exclusive plan periods
|
1/4/2024 | DD | Amyris amends DIP financing to extend maturity, milestones
|
1/4/2024 | DD | Amyris gets approval to sell JVN assets for $1.25 million
|
1/3/2024 | DD | Amyris closes sale of MenoLabs assets to Dr. Reddy’s Laboratories
|
1/2/2024 | DD | Amyris reports $36.67 million net loss for November
|
12/20/2023 | DD | Amyris gets approval of bid procedures for Lab-to-Market assets
|
12/15/2023 | DD | Amyris seeks approval of bid procedures for Lab-to-Market assets
|
12/13/2023 | DD | Amyris receives approval of disclosure statement for amended plan
|
12/12/2023 | DD | Amyris receives bankruptcy court approval of four asset sales
|
12/8/2023 | DD | Amyris asks court for 90-day extension of exclusive plan periods
|
12/7/2023 | DD | Amyris, committee fight attempt to have examiner appointed to case
|
12/4/2023 | DD | Amyris reports results of auctions for assets; sale hearing Dec. 12
|
11/22/2023 | DD | Amyris reports $26.82 million net loss for October
|
11/17/2023 | DD | Amyris’ disclosure statement lacks information, U.S. trustee says
|
11/7/2023 | DD | Amyris reports $84.58 million net loss for September
|
11/1/2023 | DD | Amyris noteholders, shareholders ask for appointment of examiner
|
10/17/2023 | DD | Amyris receives final approval of $190 million in DIP financing
|
10/16/2023 | DD | Amyris gets approval of bid procedures; auction set for Nov. 28
|
10/13/2023 | DD | Amyris files Chapter 11 reorganization plan, disclosure statement
|
10/12/2023 | DD | Amyris amends DIP financing to again push back case deadlines
|
9/28/2023 | DD | Amyris amends DIP financing to push back case deadlines
|
9/19/2023 | DD | Amyris gets further interim access to $93 million of DIP financing
|
9/19/2023 | DD | Amyris sets bid procedures for brands, seeks Nov. 28 auction
|
9/14/2023 | DD | Amyris amends DIP financing, extends case milestones
|
8/11/2023 | DD | Amyris gets interim access to $70 million of DIP financing
|
8/11/2023 | CV | Market Commentary: Convertible primary caps one of the busiest weeks YTD; Shockwave jumps on debut; Amyris settles
|
8/10/2023 | CVDDPV | Amyris files Chapter 11 bankruptcy, lines up $190 million DIP loan
|
8/3/2023 | PV | Amyris secures $20 million 12% term loan due 2024 via Foris’ Muirisc
|
6/29/2023 | PV | Amyris gets new $50 million term loan via Anjo Ventures
|
6/5/2023 | PV | Amyris gets new $50 million term loan, amends, extends existing debt
|
12/16/2022 | PV | Amyris restates loan with DSM, draws third tranche totaling $25 million
|
11/9/2022 | CV | Market Commentary: Coinbase convertibles crumble with Bitcoin; Amyris yield cracks 38%; Affirm pressured
|
9/13/2022 | PV | Amyris gets up to $80 million two-part term loan via Foris Ventures
|
11/15/2021 | CV | Amyris greenshoe fully exercised, lifts convertibles to $690 million
|
11/12/2021 | CV | Market Commentary: 3D Systems convertibles hit the aftermarket, expand on debut; Amyris gains; Jamf drops
|
11/10/2021 | CV | Market Commentary: MGP Ingredients eyed; Amyris, Cryoport convertibles expand on debut; RingCentral gains
|
11/10/2021 | CV | Market Commentary: Morning Commentary: MGP Ingredients eyed; Amyris, Cryoport convertibles hit secondary
|
11/10/2021 | CV | New Issue: Amyris sells upsized $600 million five-year convertibles to yield 1.5%, up 35%
|
11/9/2021 | CV | Market Commentary: MGP Ingredients convertibles on tap; Amyris upsizes; SmileDirectClub notes crushed
|
11/9/2021 | CV | Market Commentary: Morning Commentary: Amyris, Cryoport convertible notes offerings eyed in early activity
|
11/8/2021 | CV | Market Commentary: Cryoport on deck; DISH active; Peloton sinks; Live Nation down outright, up on swap
|
11/8/2021 | CV | Amyris talks $400 million five-year convertible notes to yield 1.5%-2%, up 30%-35%
|
7/15/2019 | PV | Amyris gets $16 million credit facility, promissory note from Foris
|
4/15/2019 | CV | Amyris expects to fully repay 9.5% convertible notes due April 2019
|
12/7/2018 | CVLM | Amyris to repay 6.5%, 9.5% convertibles due 2019 via new notes issue
|
4/9/2018 | BWCV | Amyris convertibles holders convey wish to convert; leverage to fall
|
12/29/2016 | CVLM | Amyris to swap 3% convertibles due 2017 for 9.5% convertibles due 2019
|
9/9/2016 | PP | Amyris completes $3 million of $15 million placement of convertibles
|
5/10/2016 | PP | Amyris plans to conduct $15 million private placement of convertibles
|
4/11/2016 | PP | Amyris takes in $5 million through private placement of common stock
|
3/9/2016 | PP | Amyris to conduct $50 million at-the-market sale of common stock
|
2/19/2016 | PP | Amyris takes in $20 million through private placement of 13.5% notes
|
10/16/2015 | CV | Market Commentary: Convertibles mostly quiet; PTC Therapeutics little changed after trial news; SolarCity, Greenbrier shares down
|
10/15/2015 | PP | Market Commentary: FXCM slips; SanDisk mixed in active trade; Xilinx contracts; Amyris prices, older Amyris at 80
|
10/15/2015 | CV | Market Commentary: FXCM slips; SanDisk mixed in active trade; Xilinx contracts; Amyris prices, older Amyris at 80
|
10/15/2015 | CV | Market Commentary: Morning Commentary: SanDisk remains mixed, active; Xilinx contracts; Amyris prices, older Amyris at 80
|
10/15/2015 | CV | New Issue: Amyris prices upsized $57.6 million of 3.5-year convertibles to yield 9.5%, up 15%
|
10/14/2015 | PP | Market Commentary: SanDisk mixed on takeout chatter; Cepheid contracts after warning; Amyris offering on tap
|
10/14/2015 | CV | Market Commentary: SanDisk mixed on takeout chatter; Cepheid contracts after warning; Amyris offering on tap
|
10/14/2015 | CV | Amyris intends to price $50 million of 3.5-year convertibles
|
10/14/2015 | CV | Market Commentary: Morning Commentary: Cepheid comes in after revenue warning; Amyris plans $50 million convertibles
|
10/14/2015 | CV | Amyris intends to price $50 million of five-year convertible notes
|
7/27/2015 | PP | Amyris wraps $25 million tranche of private placement of common stock
|
2/24/2015 | PP | Amyris negotiates $50 million stock purchase agreement with Nomis Bay
|
12/31/2014 | CV | Market Commentary: Outlook 2015: U.S. convertibles primary notches multi-year high; volume expected to climb
|
5/23/2014 | CV | Market Commentary: Midday Commentary: Convertibles quiet ahead of holiday; Amyris deal prices; Allegheny Tech active
|
5/23/2014 | CV | New Issue: Amyris sells $75 million five-year convertibles to yield 6.5%, up 24%
|
5/23/2014 | CV | Market Commentary: Convertibles quiet ahead of holiday weekend; Amyris clears deal; RPM International eyed
|
5/22/2014 | CV | Amyris plans to sell $75 million five-year convertible notes to yield 6%-6.5%, up 20%-25%
|
5/22/2014 | CV | Market Commentary: Midday Commentary: New Post rises in aftermarket after upsizing; Amyris plans $75 million deal
|
5/22/2014 | CV | Market Commentary: Post rises in aftermarket after upsizing; Amyris plans $75 million deal; preferreds eyed
|
12/24/2013 | PP | Amyris will conduct $28 million private placement of convertibles
|
9/25/2013 | PP | Amyris arranges $5 million private placement of 10% convertible notes
|
8/8/2013 | PP | Amyris to conduct $60 million private placement of convertible notes
|
8/8/2013 | PP | Amyris may raise $73.1 million via placement of 5%, 10% convertibles
|
7/29/2013 | PP | Amyris concludes $20 million of $105 million placement of convertibles
|
6/10/2013 | PP | Amyris negotiates $105 million private placement of convertible notes
|
3/28/2013 | PP | Amyris takes in $5 million through private placement of common stock
|
12/28/2012 | PP | Amyris completes $42.25 million private placement of its common stock
|
9/17/2012 | PP | Amyris sells $15 million convertibles in second tranche of placement
|
7/31/2012 | PP | Amyris negotiates $105 million private placement of convertible notes
|
5/21/2012 | PP | Amyris raises $4.1 million through private placement of common stock
|
2/28/2012 | PP | Amyris details $83.73 million placements of stock, 3% convertibles
|
2/27/2012 | PP | Amyris lays out $58.7 million stock, $25 million 3% notes placement
|